enkephalin, leucine has been researched along with l 365260 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dickenson, AH; Hewett, K; Sullivan, AF | 1 |
Fournie-Zaluski, MC; Maldonado, R; Roques, BP; Valverde, O | 1 |
Fournie-Zaluski, MC; Maldonado, R; Roques, BP; Smadja, C; Turcaud, S | 1 |
Brikas, P; Buéno, L; Fioramonti, J; Kania, BF; Zaremba-Rutkowska, M | 1 |
Arend, A; Aunapuu, M; Bourin, M; Kõks, S; Kurrikoff, K; Matsui, T; Vasar, E | 1 |
5 other study(ies) available for enkephalin, leucine and l 365260
Article | Year |
---|---|
Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study.
Topics: Analgesics; Analgesics, Non-Narcotic; Animals; Anti-Anxiety Agents; Benzodiazepinones; Cholecystokinin; Electrophysiology; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Imidazoles; Indoles; Injections, Spinal; Male; Medetomidine; Meglumine; Morphine; Nerve Fibers; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Cholecystokinin; Receptors, Opioid; Spinal Cord | 1994 |
Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
Topics: Adamantane; Analgesics; Animals; Benzodiazepinones; Dipeptides; Disulfides; Drug Synergism; Enkephalins; Indoles; Male; Meglumine; Nociceptors; Pain Measurement; Phenylalanine; Phenylurea Compounds; Prodrugs; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Regression Analysis; Tail | 1994 |
Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalin antidepressant-like effects.
Topics: Analgesics; Animals; Antidepressive Agents; Benzodiazepinones; Cholecystokinin; Disulfides; Enkephalins; Male; Mice; Mice, Inbred Strains; Motor Activity; Peptide Fragments; Phenylalanine; Phenylurea Compounds; Receptors, Cholecystokinin | 1995 |
The evaluation of the role of CCK in the opioid modulation of the motility of the gastrointestinal tract in sheep.
Topics: Animals; Benzodiazepinones; Cholecystokinin; Devazepide; Electromyography; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Female; Gastrointestinal Motility; Injections, Intraventricular; Intestines; Narcotics; Phenylurea Compounds; Receptors, Cholecystokinin; Receptors, Opioid, mu; Sheep; Stomach | 1999 |
Deletion of the CCK2 receptor gene reduces mechanical sensitivity and abolishes the development of hyperalgesia in mononeuropathic mice.
Topics: Animals; Benzodiazepinones; Disease Models, Animal; Dose-Response Relationship, Drug; Dynorphins; Enkephalins; Gene Expression; Hyperalgesia; Inflammation; Ligation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naloxone; Narcotic Antagonists; Pain Measurement; Pain Threshold; Phenylurea Compounds; Pro-Opiomelanocortin; Protein Precursors; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Receptors, Opioid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sciatic Neuropathy; Time Factors | 2004 |